J&J reaches sweeping talc deal that could end decade of litigation
Johnson & Johnson said Monday it would pay an estimated $5.5 billion to resolve lawsuits alleging its baby powder and other talc products cause ovarian cancer.
Overview
Johnson & Johnson said Monday it would pay an estimated $5.5 billion to resolve lawsuits alleging its baby powder and other talc products cause ovarian cancer.
Source
Originally published at www.cnbc.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.